Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors

Given per standard care for duration of study. Regimens include Leuprolide (Lupron Depot) intramuscularly every 3 months, Goserelin acetate (Zoladex) subcutaneously every 4 weeks, or degarelix (Firmagon) subcutaneously every month per standard of care.

Given once per every 3 weeks for cycle 1-6 intravenously and then every 4 weeks during subsequent cycles, at predetermined dosage; up to 28 cycles total.

Given once every 3 weeks intravenously at pre determined dosage for cycle 1-6.